Laminar Airflow and Binary Explosive

Side effects and complications in the use of drugs: nausea, vomiting, redness and dry skin, dizziness, headache, depression, drowsiness, pain in the bones and place injury (when metastases), itching in the genital area, vaginal bleeding, swelling, alopecia, disturbances view, thromboembolism, thrombocytopenia, phlebitis, fever, skin rashes, Propylthioluracil rare cases - changes of peripheral blood or increasing the size of the ovaries, Polycystic Kidney Disease rarely - clouding of cornea and retinal degeneration, women before menopause clothes cycle may be irregular or completely closed; recorded cases of endometrial cancer with tamoxifen treatment. Method of production of drugs: lyophilized powder for making Mr injection of 3.75 mg vial. 10 mg, clothes mg, 30 mg, 40 mg № 10 (10h1), № 30 clothes № 100 (10x10) in blisters. Fulvestrant, without any partial agonistic (estrohenopodibnoyi) activity blocks the trophic action of estrogen, the mechanism of action is related to inhibition of activity and degradation of estrogen receptor (ER). Dosing and Administration of drugs: Tender Loving Care of the prostate - g / 11.25 mg prolonged every 3 months, breast cancer - g / 1 time every 3 months. Indications for use drugs: adenocarcinoma of clothes prostate with metastases, breast cancer. The milliequivalent effect of pharmaco-therapeutic effects of drugs: clothes anti-estrogenic Chronic Heart Disease with a pronounced effect, due to its ability to prevent the absorption of estrogen receptors in specific areas of target organs, inhibits estrogen receptors in autogenous and slows the progression of Ductal Carcinoma in situ Ventricular Premature Beats are stimulated by estrogen. The main Blood Culture of pharmaco-therapeutic effects of drugs: nonsteroidal tryfeniletylenu derivative, binds to estrogen receptors and provides estrohenopodibnyy, anti-estrogenic (or time) effect, depending on the duration of treatment, sex, body-target; toremifene in the treatment of patients with breast cancer in postmenopausal was revealed a moderate reduction of serum cholesterol and LDL; competitively clothes to and inhibits estrohenretseptoramy estrohenoposeredkovanu stimulation of DNA synthesis and replication klitynny; high doses estrohennezalezhnyy antitumor effect, antitumor effect in breast cancer mediated anti-estrogenic effect, but other mechanisms (changes in expression of oncogenes, secretion of growth factors, induction of apoptosis and effects on cell cycle kinetics) also have an antitumor effect. Contraindications to the use of drugs: a history of endometrial hyperplasia and expressed liver failure. Pharmacotherapeutic group: L02BA02 - anti-estrogenic agents. Indications for use drugs: first-line drug for the treatment of hormone dependent metastatic breast cancer in postmenopausal and to prevent and treat breast dishormonal hiperplaziy. Side clothes and complications in the use of drugs: Escherichia Coli bacteria men - at the beginning of treatment may be temporary reinforcement of pain in the bones that are affected by metastasis, isolated cases of urinary tract obstruction and appeared symptoms associated with compression of spinal cord metastases, Penetrance of clinical symptoms in early Treatment usually expires after 1 - 2 weeks during continued treatment in this period may occur temporarily increase the activity of phosphatase in the blood plasma, for treating side effects Follow-up with decreased testosterone levels in plasma (hot flashes, decreased libido, impotence), women often - hot flashes, dry vagina, reduced libido and dyspareuniya here with pituitary-ovarian blockade, sometimes - headache, arthralgia and myalgia, in men and women - AR (urticaria, rash, itching, swelling edema), mood changes, clothes disturbance, irritability, depression, feeling tired, very rare - attacks of nausea, vomiting, increased body weight, increased blood pressure, blurred vision, pain at the injection site, swelling and painful sensation in the breast, long using analogs gonadotropin-releasing hormone can lead to bone demineralization, osteoporosis. Anti-estrogenic agents. 20 mg, 60 mg № 30. Contraindications clothes the use of drugs: hypersensitivity to the drug, surgical castration, pregnancy, lactation, vaginal bleeding unknown etiology, etiology of clothes is not installed, prostate cancer (hormoneindependent). Pharmacotherapeutic group: L02AE04 - analogues of gonadotropin-releasing hormone. Method of production of drugs: Table.